Top compounds associated with response to CREBL2


Feature Type Standardized
Nominal ANOVA
mRNA CHIR-99021 CTRPv2 pan-cancer AAC -0.071 0.04
mRNA MLN2480 CTRPv2 pan-cancer AAC 0.12 0.04
mRNA NG-25 GDSC1000 pan-cancer AAC -0.063 0.04
mRNA WZ4002 CTRPv2 pan-cancer AAC -0.097 0.04
mRNA tivantinib CTRPv2 pan-cancer AAC -0.098 0.04
mRNA KU-55933 GDSC1000 pan-cancer AAC -0.075 0.05
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.05
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.072 0.05
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.05
mRNA Crizotinib CCLE pan-cancer AAC 0.094 0.05
Download CSV